“The Specialty Pharmacist’s Role in the Management of Opportunistic Infections in the Treatment of HIV/AIDS” (1.5 Hours)

MODULE HIV-106

TITLE -
The Specialty Pharmacist’s Role in the Management of Opportunistic Infections in the Treatment of HIV/AIDS

TARGET AUDIENCE - Target audiences for this program are Specialty Pharmacists, Pharmacists, Clinical Pharmacists, Specialty Pharmacy executives, Pharmacy Directors, Chief Pharmacy Officers, Nurses, and Infusion Nurses.

LEARNING OBJECTIVES - 
After completing the program, Specialty Pharmacists, Pharmacists, Clinical Pharmacists, Specialty Pharmacy executives, Pharmacy Directors, Chief Pharmacy Officers, Nurses, and Infusion Nurses along with other healthcare practitioner participants will be able to:

  1. Describe the common Opportunistic Infections (OIs) associated with declining CD4 counts
  2. Recognize the medications used for both prevention and  treatment as well as and the necessary medication monitoring for management of the following OIs
    1. Mucocutaneous Candidiasis (oropharyngeal and esophageal)
    2. Pneumocystis jiroveci pneumonia (PCP)
    3. Cryptococcus neoformans (Cryptococcal meningitis)
    4. Toxoplasmosis
    5. Mycobacterium tuberculosis
    6. Mycobacterium Avium Complex (MAC)
    7. Cytomegalovirus (CMV)
  3. Provide recommendation for the management of any side effects associated with particular treatments for OIs
  4. Identify the three biggest barriers to adherence and compliance for the HIV patient concerning OIs
  5. Recognize the three most important clinical and three non-clinical considerations concerning the specialty pharmacist in HIV OIs

Faculty Disclosures:

Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/ services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by the Specialty Pharma Education Center for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Pharmacist continuing education credit

Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmaceutical education. This program is approved for 1.5 hours (0.15CEUs) of continuing pharmacy education credit.  Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test.   Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.
ACPE # 0761-9999-13-187-H02-P

Knowledge based activity

Nursing continuing education credit

Educational Review Systems is an approved provider of continuing education in nursing by ASNA, an accredited provider by the ANCC/Commission on Accreditation. Provider # 5-115.  This program is approved for 1.5 hours of continuing nursing education.

Educational Review Systems is also approved for nursing continuing education by the state of California, the state of Florida and the District of Columbia.

Course release date 5/20/2013

Course expires 5/20/2016

Credit Information

Activity Number Credit Amount Accreditation Period
0761-9999-13-187-H02-N 1.5 hours of CNE from July 01, 2013